Literature DB >> 28320719

Antibiotic Effects on Methicillin-Resistant Staphylococcus aureus Cytoplasmic Peptidoglycan Intermediate Levels and Evidence for Potential Metabolite Level Regulatory Loops.

Harika Vemula1, Navid J Ayon1, Alloch Burton1, William G Gutheil2.   

Abstract

Cytoplasmic peptidoglycan (PG) precursor levels were determined in methicillin-resistant Staphylococcus aureus (MRSA) after exposure to several cell wall-targeting antibiotics. Three experiments were performed: (i) exposure to 4× MIC levels (acute); (ii) exposure to sub-MIC levels (subacute); (iii) a time course experiment of the effect of vancomycin. In acute exposure experiments, fosfomycin increased UDP-GlcNAc, as expected, and resulted in substantially lower levels of total UDP-linked metabolite accumulation relative to other pathway inhibitors, indicating reduced entry into this pathway. Upstream inhibitors (fosfomycin, d-cycloserine, or d-boroalanine) reduced UDP-MurNAc-pentapeptide levels by more than fourfold. Alanine branch inhibitors (d-cycloserine and d-boroalanine) reduced d-Ala-d-Ala levels only modestly (up to 4-fold) but increased UDP-MurNAc-tripeptide levels up to 3,000-fold. Downstream pathway inhibitors (vancomycin, bacitracin, moenomycin, and oxacillin) increased UDP-MurNAc-pentapeptide levels up to 350-fold and UDP-MurNAc-l-Ala levels up to 80-fold, suggesting reduced MurD activity by downstream inhibitor action. Sub-MIC exposures demonstrated effects even at 1/8× MIC which strongly paralleled acute exposure changes. Time course data demonstrated that UDP-linked intermediate levels respond rapidly to vancomycin exposure, with several intermediates increasing three- to sixfold within minutes. UDP-linked intermediate level changes were also multiphasic, with some increasing, some decreasing, and some increasing and then decreasing. The total (summed) UDP-linked intermediate pool increased by 1,475 μM/min during the first 10 min after vancomycin exposure, providing a revised estimate of flux in this pathway during logarithmic growth. These observations outline the complexity of PG precursor response to antibiotic exposure in MRSA and indicate likely sites of regulation (entry and MurD).
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  LC-MS/MS; MRSA; Staphylococcus aureus; antibiotic; antibiotic resistance; cell wall; metabolomics; peptidoglycan

Mesh:

Substances:

Year:  2017        PMID: 28320719      PMCID: PMC5444159          DOI: 10.1128/AAC.02253-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  42 in total

Review 1.  Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis.

Authors:  Miha Kotnik; Petra Stefanic Anderluh; Andrej Prezelj
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

2.  A protocol for the investigation of the intracellular Staphylococcus aureus metabolome.

Authors:  Hanna Meyer; Manuel Liebeke; Michael Lalk
Journal:  Anal Biochem       Date:  2010-03-06       Impact factor: 3.365

Review 3.  Penicillin-binding proteins: evergreen drug targets.

Authors:  Jean-Marie Frère; Malcolm G P Page
Journal:  Curr Opin Pharmacol       Date:  2014-10-14       Impact factor: 5.547

4.  On the mechanism of action of vancomycin: inhibition of peptidoglycan synthesis in Gaffkya homari.

Authors:  W P Hammes; F C Neuhaus
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

5.  Cytoplasmic peptidoglycan intermediate levels in Staphylococcus aureus.

Authors:  Harika Vemula; Navid J Ayon; William G Gutheil
Journal:  Biochimie       Date:  2015-11-21       Impact factor: 4.079

6.  Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W.

Authors:  M P Lambert; F C Neuhaus
Journal:  J Bacteriol       Date:  1972-06       Impact factor: 3.490

Review 7.  The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis.

Authors:  Eric Sauvage; Frédéric Kerff; Mohammed Terrak; Juan A Ayala; Paulette Charlier
Journal:  FEMS Microbiol Rev       Date:  2008-02-11       Impact factor: 16.408

8.  Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin.

Authors:  M Nieto; H R Perkins
Journal:  Biochem J       Date:  1971-08       Impact factor: 3.857

Review 9.  Lipid Flippases for Bacterial Peptidoglycan Biosynthesis.

Authors:  Natividad Ruiz
Journal:  Lipid Insights       Date:  2016-01-13

Review 10.  Core Steps of Membrane-Bound Peptidoglycan Biosynthesis: Recent Advances, Insight and Opportunities.

Authors:  Alvin C K Teo; David I Roper
Journal:  Antibiotics (Basel)       Date:  2015-11-03
View more
  4 in total

1.  LC-MS/MS-Based Separation and Quantification of Marfey's Reagent Derivatized Proteinogenic Amino Acid DL-Stereoisomers.

Authors:  Navid J Ayon; Amar Deep Sharma; William G Gutheil
Journal:  J Am Soc Mass Spectrom       Date:  2018-11-12       Impact factor: 3.109

2.  A New Perspective on the Antimicrobial Mechanism of Berberine Hydrochloride Against Staphylococcus aureus Revealed by Untargeted Metabolomic Studies.

Authors:  Shu Wu; Kun Yang; Yuhang Hong; Yanju Gong; Jiajia Ni; Ni Yang; Weijun Ding
Journal:  Front Microbiol       Date:  2022-07-13       Impact factor: 6.064

3.  Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and van Operon mRNA Levels in VanA-Type Vancomycin-Resistant Enterococcus faecium.

Authors:  Shivani Gargvanshi; Harika Vemula; William G Gutheil
Journal:  J Bacteriol       Date:  2021-07-22       Impact factor: 3.490

4.  New insights into the resistance mechanism for the BceAB-type transporter SaNsrFP.

Authors:  Julia Gottstein; Julia Zaschke-Kriesche; Sandra Unsleber; Irina Voitsekhovskaia; Andreas Kulik; Lara V Behrmann; Nina Overbeck; Kai Stühler; Evi Stegmann; Sander H J Smits
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.